ËÑË÷

ÏÙÏà¹Ø²¡¶¾°ü×°

ÖØ×éÏÙÏà¹Ø²¡¶¾£¨recombination adeno-associated virus, rAAV£©ÊÇÒ»ÖÖÎÞ°üĤµÄµ¥Á´DNAȱÏÝÐͲ¡¶¾£¬£¬£¬£¬£¬£¬Ëü¾ßÓÐÒÔÏÂÓŵ㣺Çå¾²ÐԸߣ¬£¬£¬£¬£¬£¬²»Ö²¡£¡£¡£»£»£»ÃâÒßÔ­ÐԵͣ¬£¬£¬£¬£¬£¬Ñ¬È¾ËÞÖ÷ϸ°ûºóºÜÉÙÒý·¢ÃâÒß·´Ó¦£»£»£»ËÞÖ÷¹æÄ£¹ã£¬£¬£¬£¬£¬£¬¿É¸ßÐ§Ñ¬È¾ÆÆËéºÍ·ÇÆÆËéϸ°û£»£»£»±í´ïÎȹÌÇÒ³¤ÆÚ£¬£¬£¬£¬£¬£¬ÔÚ·ÇÆÆËéϸ°ûÖпÉÒ»Á¬±í´ïÍâÔ´»ùÒò¡£¡£¡£rAAVµÄÓ¦ÓÃÆÕ±é£¬£¬£¬£¬£¬£¬Ö÷ÒªÓÃÓÚ»ùÒò¹¦Ð§Ñо¿¡¢¼²²¡Ä£×Ó¹¹½¨ºÍ»ùÒòÖÎÁƵÈ¡£¡£¡£

ЧÀÍÏêÇé

ЧÀÍÀàÐÍ ÇóýrAAV/¹ý±í´ïrAAV/×ÌÈÅrAAV/CRISPRÎÄ¿ârAAV
½»¸¶±ê×¼ 1.µÎ¶È±¨¸æ
2.ͼÆ×
3.rAAV
ÖÜÆÚ/¼ÛÇ® ¿ìÖÁ2ÖÜ£¬£¬£¬£¬£¬£¬4400ÔªÆð ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾? ÔÚÏß×Éѯ
ÍêÃÀÕæÈËÓµÓгÉÊìµÄ²¡¶¾°üװƽ̨£¬£¬£¬£¬£¬£¬¿ÉÌṩ¶àÖÖѪÇåÐÍrAAVµÄ¶¨ÖÆ»¯°üװЧÀÍ£¬£¬£¬£¬£¬£¬È·±£²úÆ·¾ß±¸¸ßµÎ¶È¡¢¸ßѬȾ»îÐԺ͸ߴ¿¶È£¬£¬£¬£¬£¬£¬¿ÉÖª×ã¶àÖÖ¿ÆÑм¶µÄʵÑéÐèÇó

ЧÀÍÓÅÊÆ

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÖÊÁ¿¿É¿¿
µÎ¶È¸ß´ï1E+13GC/mlÒÔÉÏ£»£»£»´¿¶È´óÓÚ95%£¬£¬£¬£¬£¬£¬ÄÚ¶¾ËØÐ¡ÓÚ10EU/ml
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ѪÇåÐ͸»ºñ
Ìṩ15ÖÖÒÔÉϲî±ðµÄѪÇåÐÍÑ¡Ôñ                     
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ÔØÌåÀàÐ͸»ºñ
³£¼ûÆô¶¯×ÓºÍÓ«¹â±êÇ©¶àÖÖ´îÅäµÄÔØÌå¿â£¬£¬£¬£¬£¬£¬½öÐè×é×°Ä¿µÄ»ùÒò£¬£¬£¬£¬£¬£¬´ó´óËõ¶ÌʵÑéÖÜÆÚºÍ±¾Ç®
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
ЧÀÍÖÜÈ«
¿Éƾ֤ʵÑéÐèÇóÌṩ´ÓÔØÌåÉè¼Æµ½²¡¶¾°ü×°µÄһվʽЧÀÍ

ЧÀÍÀàÐÍ

¿Éƾ֤¿Í»§ÐèÇ󣬣¬£¬£¬£¬£¬Ìṩ¶àÖÖÀàÐ͵ÄÏÙÏà¹Ø²¡¶¾°üװЧÀÍ¡£¡£¡£
1£©»ùÒò±í´ïrAAV
2£©»ùÒòÇóýrAAV
3£©»ùÒò×ÌÈÅrAAV

²úÆ·¹æ¸ñ

±ê×¼¹æ¸ñ°ü×° 1E+12GC£¬£¬£¬£¬£¬£¬≥5E+12GC/ml
Öеȹæ¸ñ°ü×° 5E+12GC£¬£¬£¬£¬£¬£¬≥1E+13GC/ml
´ó¹æ¸ñ°ü×° 1E+13GC£¬£¬£¬£¬£¬£¬≥1E+13GC/ml

½»¸¶±ê×¼

1£©rAAV£¨º¬±ÈÕÕrAAV£©
2£©µÎ¶È±¨¸æ
3£©ÔØÌåͼÆ×
4£©²Ù×÷˵Ã÷

ЧÀÍÁ÷³Ì

 

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
 

ͨÀýѪÇåÐÍ×éÖ¯ÊÈÐÔÍÆ¼ö

ѪÇåÐÍ ×éÖ¯ÊÈÐÔ
AAV1 ƽ»¬¼¡, ÖÐÊàÉñ¾­ÏµÍ³, ·Î, ÊÓÍøÄ¤, ÄÚ¶ú×éÖ¯, ÒÈÏÙ, ÐÄÔà, ¸Î
AAV2 ƽ»¬¼¡, ÖÐÊàÉñ¾­ÏµÍ³, ¸Î, Éö, ÊÓÍøÄ¤, ÄÚ¶ú×éÖ¯</span >
AAV3 ƽ»¬¼¡, ¸Î, ·Î
AAV4 ÖÐÊàÉñ¾­ÏµÍ³, ÊÓÍøÄ¤, ·Î, Éö
AAV5 ƽ»¬¼¡, ÖÐÊàÉñ¾­ÏµÍ³, ·Î, ÊÓÍøÄ¤
AAV6 ƽ»¬¼¡, ÐÄÔà, ·Î, Ö¬·¾×éÖ¯, ¸Î
AAV6.2 ·Î, ¸Î, ÄÚ¶ú×éÖ¯
AAV7 ƽ»¬¼¡, ÊÓÍøÄ¤, ÖÐÊàÉñ¾­ÏµÍ³, ¸Î
AA8 ƽ»¬¼¡, ÖÐÊàÉñ¾­ÏµÍ³, ÊÓÍøÄ¤, ÄÚ¶ú×éÖ¯, ¸Î, ÒÈÏÙ, ÐÄÔà, Éö, Ö¬·¾×éÖ¯
AAV9 ƽ»¬¼¡, ·Î, ¸Î, ÐÄÔà, ÒÈÏÙ, ÖÐÊàÉñ¾­ÏµÍ³, ÄÔ£¬£¬£¬£¬£¬£¬ÊÓÍøÄ¤, ÄÚ¶ú×éÖ¯, ØºÍè, Éö
AAV-rh10 ƽ»¬¼¡, ·Î, ¸Î, ÐÄÔà, ÒÈÏÙ, ÖÐÊàÉñ¾­ÏµÍ³, ÊÓÍøÄ¤, Éö
AAV-DJ ¸Î, ÐÄÔà, Éö, Æ¢
AAV-DJ/8 ¸Î, ÄÔ, Æ¢
AAV-PHP.eB ÖÐÊàÉñ¾­ÏµÍ³
AAV-PHP.S ÍâÖÜÉñ¾­ÏµÍ³
AAV2-retro ¼¹Éñ¾­
AAV2-QuadYF ÄÚÆ¤Ï¸°û
AAV2.7m8 ÊÓÍøÄ¤, ÄÚ¶ú×éÖ¯
 

AAV²úÆ·ÏÖ»õ

 
 

AAVÏÙÏà¹Ø²¡¶¾µÄÓ¦ÓÃ

1.  CreÖØ×éøAAV£ºÓ¦ÓÃCre/0xPϵͳ¿É¿ìËÙ¸ßЧµØÊµÏÖÌØ¶¨Ï¸°û¡¢×éÖ¯»ò¸öÌåˮƽÉÏÌØ¶¨»ùÒòµÄµ÷¿Ø£¬£¬£¬£¬£¬£¬¿É¿ìËÙʵÏÖ×éÖ¯ÌØÒìÐÔ±í´ïµÄ¶¯ÎïÄ£×Ó¹¹½¨¡£¡£¡£

2.  ¹âÒÅ´«¡¢»¯Ñ§ÒÅ´«AAV£º¹âÒÅ´«AAV¿ÉÓÃÓÚÑо¿Éñ¾­ÍøÂ繦Ч¡£¡£¡£»£»£»¯Ñ§ÒÅ´«AAV¿ÉÓÃÓÚ̽Ë÷Í»±äÂѰ׺ͻ¯Ñ§Ò©ÎïµÄÏ໥×÷Óᣡ£¡£

3.  EGFPÓ«¹âÂѰ××ÔÖ÷רÀûѪÇåÐÍAAV£ºÉñ¾­°ÐÏòÐÔºÍÑÛ×éÖ¯°ÐÏòÐÔÍ»±äÌ岡¶¾¡£¡£¡£

4.  EGFPÓ«¹âÂѰ×ͨÀýѪÇåÐÍAAV¡¢Í»±äÌåѪÇåÐÍAAVºÍÌØÒìÐÔÆô¶¯×ÓAAV£ºÓ¦ÓÃÓÚϸ°ûʵÑé»ò¶¯ÎïÌåÄÚÑо¿×÷ΪʵÑé±ÈÕÕ.

5.  Luciferase±¨¸æ»ùÒòAAVºÍmCherryÓ«¹âÂѰ×AAV£ºÓ¦ÓÃÓÚϸ°ûʵÑé»ò¶¯ÎïÌåÄÚÑо¿×÷ΪʵÑé±ÈÕÕ¡£¡£¡£

Advantage and Characteristic

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic
ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾
Optimazied Strategy
We have create a unique sgRNA Design Logic

¾«Ñ¡¿Í»§ÎÄÕÂ

IF=50.5
nature

È«ÇòÁè¼ÝÒ»°ëµÄ¸Îϸ°û°©£¨HCC£©²¡Àý±¬·¢ÔÚÖйú£¬£¬£¬£¬£¬£¬µ«ÏÖÔÚÕë¶ÔÖйúÈËȺÖÐÒÒÐ͸ÎÑײ¡¶¾£¨HBV£©Ïà¹ØHCCµÄÈ«»ùÒò×éÆÊÎöÑо¿ºÜÊÇÓÐÏÞ¡£¡£¡£ÎªÁËÍ»ÆÆÕâÖÖÏÞÖÆ£¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±Æô¶¯ÁË“Öйú¸Î°©Í¼Æ×ÏîÄ¿”£¨CLCA£©£¬£¬£¬£¬£¬£¬Ö¼ÔÚ¶ÔÖйúÈËȺÖеÄHCC¾ÙÐдó¹æÄ£µÄÈ«»ùÒò×éÆÊÎöÒÔÃ÷È·ÆäÆæÒìµÄ·¢²¡»úÖÆºÍ½ø»¯Àú³Ì¡£¡£¡£¸ÃÏîÄ¿¶Ô494ÀýHCCÖ×ÁöÑù±¾¾ÙÐÐÁËÉî¶ÈÈ«»ùÒò×é²âÐò£¨Æ½¾ù²âÐòÉî¶ÈΪ120×£©£¬£¬£¬£¬£¬£¬²¢ÆÊÎöÁËÆ¥ÅäµÄ±ÈÕÕѪҺÑù±¾£¬£¬£¬£¬£¬£¬Õ¹ÏÖÁËHBVÏà¹ØHCCµÄÏêϸ»ùÒò×éÌØÕ÷¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬£¬£¬£¬³ýÁËÒÑÖªµÄ±àÂëÇøÇý¶¯»ùÒò£¨ÈçTP53ºÍCTNNB1£©Í⣬£¬£¬£¬£¬£¬»¹±£´æ6¸öеıàÂëÇøÇý¶¯»ùÒò£¨°üÀ¨FGA£©ºÍ31¸ö·Ç±àÂëÇøÇý¶¯»ùÒò¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Ñо¿»¹Õ¹ÏÖ5ÖÖеÄÍ»±äÌØÕ÷£¨°üÀ¨SBS_H8£©£¬£¬£¬£¬£¬£¬ÒÔ¼°HBVÕûºÏÐγÉϸ°ûÍâ»·×´DNA£¨ecDNA£©µÄÕ÷Ï󣬣¬£¬£¬£¬£¬ÕâЩecDNA¿Éµ¼Ö°©»ùÒòÀ©ÔöºÍ±í´ïÔöÌí¡£¡£¡£Í¨¹ý¹¦Ð§Ñé֤ʵÑ飬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±Ö¤ÊµÁËFGA¡¢PPP1R12BºÍKCNJ12µÈ»ùÒòµÄÍ»±äÄܹ»ÏÔÖøÓ°ÏìHCCϸ°ûµÄÔöÖ³¡¢Ç¨áãºÍÇÖÏ®ÄÜÁ¦¡£¡£¡£ÕâÏîÑо¿Ð§¹û²»µ«¸»ºñÁËÈËÃǶÔHCC»ùÒò×éѧµÄÃ÷È·£¬£¬£¬£¬£¬£¬Ò²ÎªHCCµÄÕï¶ÏºÍÖÎÁÆÌṩÁËеÄDZÔڰеã¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ºòÑ¡Çý¶¯Òò×Ӹſö

IF=27.4
Advanced material

¼¡ëìËðÉ˼±ÐÔÑ×Ö¢ÆÚÖУ¬£¬£¬£¬£¬£¬¾ÞÊÉϸ°ûÌ«¹ý¼¤»î»áµ¼Ö±àÂë¹ÇÇÅÂѰ×OPNµÄSPP1¹ý±í´ï£¬£¬£¬£¬£¬£¬Ó°Ïì×éÖ¯ÔÙÉú¡£¡£¡£CRISPR-Cas13ÓÉÓÚ¾ßÓÐRNA±à¼­ºÍ¿ìËÙ½µ½âµÄÄÜÁ¦£¬£¬£¬£¬£¬£¬ÔÚ×éÖ¯ÐÞ¸´·½Ãæ¾ßÓÐÖØ´óDZÁ¦£¬£¬£¬£¬£¬£¬µ«È±·¦ºÏÊÊÓÐÓõĵÝËÍÒªÁì¡£¡£¡£¶Ô´Ë£¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±ÏµÍ³É¸Ñ¡ÁËÕë¶Ô¾ÞÊÉϸ°ûµÄÑôÀë×Ó¾ÛºÏÎ£¬£¬£¬£¬£¬¿ª·¢ÁËÒ»ÖÖÄܹ»¸ßЧµÝËÍCas13ºËÌǺËÂѰ׸´ºÏÎCas13 RNP£©½øÈë¾ÞÊÉϸ°ûµÄÄÉÃ×´ØÔØÌå¡£¡£¡£Í¨¹ý·´Ó¦ÐÔÑõÖÖ£¨ROS£©ÏìÓ¦ÐÔÊÍ·Å»úÖÆ£¬£¬£¬£¬£¬£¬¸ÃϵͳÄܹ»ÔÚ¼¡ëìËðÉ˵ļ±ÐÔÑ×֢΢ÇéÐÎÖÐÌØÒìÐÔÒÖÖÆ¾ÞÊÉϸ°ûÖÐSPP1µÄ¹ý±í´ï¡£¡£¡£ÊµÑéЧ¹ûÅú×¢£¬£¬£¬£¬£¬£¬ÕâÖÖ°ÐÏò²ßÂÔÏÔÖøïÔÌ­ÁËËðÉËÓÕµ¼µÄSPP1±¬·¢¾ÞÊÉϸ°ûµÄ·ºÆð£¬£¬£¬£¬£¬£¬½µµÍÁ˳ÉÏËάϸ°ûµÄ¼¤»î£¬£¬£¬£¬£¬£¬²¢¼õÇáÁ˼¡ëìÖÜΧµÄÕ³Á¬ÐγÉ¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬¸ÃÑо¿»¹Õ¹ÏÖÁËSPP1ͨ¹ýCD44/AKTÐźÅͨ·Ôö½ø³ÉÏËάϸ°û»î»¯ºÍǨáãµÄ»úÖÆ£¬£¬£¬£¬£¬£¬²¢Í¨¹ýÒÖÖÆÕâһͨ·ÓÐÓûº½âÁ˼¡ëìËðÉ˺óµÄÕ³Á¬ÎÊÌâ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ÓÃÓÚPAÖÎÁƵľÞÊÉϸ°ûÃâÒß΢ÇéÐ줻îmRNA±à¼­²ßÂÔµÄʾÒâͼ

IF=12.8
Biomaterials

¼¹ËèËðÉË£¨SCI£©ÊÇÒ»ÖÖµ¼Ö¸ÐÊÜ×ÔÖ÷Éñ¾­ºÍÔ˶¯¹¦Ð§µÄÓÀÊÀÐÔË𺦵ÄÑÏÖØÖ²ÐÐÔ¼²²¡¡£¡£¡£¸Éϸ°ûÁÆ·¨£¬£¬£¬£¬£¬£¬ÓÈÆäÊǼä³äÖʸÉϸ°û£¨MSCs£©£¬£¬£¬£¬£¬£¬ÔÚSCIÖÎÁÆÖÐÕ¹ÏÖ³öÖØ´óDZÁ¦µ«ÆäÔÙÉúÄÜÁ¦ÓÐÏÞ£¬£¬£¬£¬£¬£¬ÕâÏÞÖÆÁËÆäÔÚ×éÖ¯ÔÙÉúÖеÄÓ¦Óᣡ£¡£Ñо¿ÍŶÓÊӲ쵽ABPCsÑÜÉúµÄEVs£¨EVsABPC£©¿ÉÄÜЯ´øÔö½ø×éÖ¯ÔÙÉúµÄÉúÎï»îÐÔÐźÅ£¬£¬£¬£¬£¬£¬Òò´ËËûÃÇ´Ó¹½ÇÑ¿»ù×æÏ¸°û£¨ABPCs£©ÖÐÌáÈ¡²¢ÐÞÊÎÁËϸ°ûÍâÄÒÅÝ£¨EVsABPC£©£¬£¬£¬£¬£¬£¬²¢½«ÆäÓ¦ÓÃÓÚ¼¹ËèËðÉË£¨SCI£©µÄÖÎÁÆÑо¿¡£¡£¡£Ñо¿Ö°Ô±·¢Ã÷EVsABPCÄܹ»ÏÔÖøÔöÇ¿Éñ¾­¸Éϸ°û£¨NSCs£©µÄÔöÖ³£¬£¬£¬£¬£¬£¬Ôö½øÖáÍ»Éú³¤£¬£¬£¬£¬£¬£¬ïÔÌ­Éñ¾­ÔªµòÍö£¬£¬£¬£¬£¬£¬²¢Í¨¹ýµ÷ÀíÑ×Ö¢·´Ó¦½«¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1Ðͼ«»¯Îª¿¹Ñ×µÄM2ÐÍ¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬¾­Óɹ¤³Ì»¯Ë¢ÐµÄEVsABPC£¨Í¨¹ý¼¤»îϸ°û´©Í¸ëÄÐÞÊΣ©Äܹ»¸üÓÐÓõذÐÏòSCIËðÉ˲¿Î»£¬£¬£¬£¬£¬£¬ÏÔÖø¸ÄÉÆÉñ¾­ÔÙÉúºÍÔ˶¯¹¦Ð§»Ö¸´¡£¡£¡£ÕâЩЧ¹ûÅú×¢£¬£¬£¬£¬£¬£¬EVsABPCÊÇÒ»ÖÖ¼«¾ßDZÁ¦µÄSCIÖÎÁƺòÑ¡¼Æ»®¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=12.2
Journal of Hazardous Materials

S-Òì±û¼×²Ý°·£¨S-MET£©ÊÇÎÒ¹úÉú²úºÍʹÓÃÁ¿×î´óµÄ³ý²Ý¼ÁÖ®Ò»£¬£¬£¬£¬£¬£¬Æä»¯Ñ§ÌØÕ÷µ¼ÖÂÆä¿ÉÔÚÍÁÈÀÖг¤ÆÚ±£´æÒÔ¼°ÈÝÒ×ͨ¹ýÁÜÈܺͳÁ½µÎÛȾµØ±íË®ºÍµØÏÂË®£¬£¬£¬£¬£¬£¬×îÖÕÓ°ÏìÖ²ÎïÉú³¤ºÍͨ¹ýʳÎïÁ´Î£º¦ÈËÀàÉúÃü¿µ½¡¡£¡£¡£¼øÓÚÏÖÓмì²âÒªÁìµÄ¾ÖÏÞÐԺͶԸßЧÆÊÎö¼¼ÊõµÄÆÈÇÐÐèÇ󣬣¬£¬£¬£¬£¬¸ÃÑо¿ÒÔS-metolachlorΪ¹¤¾ß£¬£¬£¬£¬£¬£¬Ê¹Óò¸È鶯Îï±í´ïϵͳÌìÉúÏà¹ØÖØ×鿹Ìå¡£¡£¡£ÔÚÀֳɱí´ï¿¹ÌåµÄ»ù´¡ÉÏ£¬£¬£¬£¬£¬£¬Àֳɽ¨ÉèÁË»ùÓÚÕâЩ¿¹ÌåµÄÃâÒ߯ÊÎöÒªÁ죬£¬£¬£¬£¬£¬ÓÃÓÚ¼à²âÇéÐÎË®ÑùÖеÄS-Òì±û¼×²Ý°·²ÐÁô¡£¡£¡£icELISAЧ¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ÖØ×鿹ÌåµÄѸËٶȺÍÌØÒìÐÔÓëÇ×±¾µ¥¿¹ÏàËÆ£¬£¬£¬£¬£¬£¬¿É¼á³ÖÔ­ÓеÄÉúÎïѧ»îÐÔ£¬£¬£¬£¬£¬£¬¹ØÓÚ½­Ë®¡¢Å©ÌïË®ºÍ×ÔÀ´Ë®ÖеÄS-MET£¬£¬£¬£¬£¬£¬¾ßÓÐÓÅÒìµÄ׼ȷÐÔºÍÖØ¸´ÐÔ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

IF=10.7
Biosensors and Bioelectronics

ϸСRNA£¨miRNA£©ÊÇÒ»ÀàСµÄ·Ç±àÂëRNA·Ö×Ó£¬£¬£¬£¬£¬£¬Í¨¹ýÓëÌØ¶¨°Ð»ùÒòµÄÐÅʹRNA£¨mRNA£©Ï໥×÷ÓÃÀ´µ÷¿Ø»ùÒò±í´ï¡£¡£¡£miRNAÔÚ¶àÖÖ¼²²¡µÄ±¬·¢¡¢Éú³¤Àú³ÌÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ«£¬£¬£¬£¬£¬£¬±»ÒÔΪÊǼ«¾ßDZÁ¦µÄ¼²²¡ÉúÎï±ê¼ÇÎï¡£¡£¡£¸ÃÑо¿Ê¹ÓÃCRISPR/Cas12a¿ª·¢ÁËÒ»ÖÖΪDBmRCAµÄÐÂÐÍmiRNA¼ì²â¼¼Êõ¡£¡£¡£¸Ã¼¼ÊõʹÓÃÎÞÅþÁ¬Ã¸µÄÑÆÁå̽ÕëºÍ¸ßѸËٶȵÄCRISPR/Cas12aÐźÅÊä³ö²ßÂÔ£¬£¬£¬£¬£¬£¬ÊµÏÖÁËÔÚ30·ÖÖÓÄÚ¶ÔmiRNAµÄ¸ß¾«¶È¶¨Á¿ÆÊÎö¡£¡£¡£Ñо¿ÍŶÓͨ¹ýÁÙ´²Ñù±¾ÑéÖ¤Á˸ü¼ÊõµÄÓÐÓÃÐÔ£¬£¬£¬£¬£¬£¬·¢Ã÷miR-200aºÍmiR-126Ôڷΰ©×éÖ¯Öеıí´ïˮƽÏÔÖø½µµÍ£¬£¬£¬£¬£¬£¬ÇҸü¼ÊõÓë¹Å°åÒªÁìЧ¹ûÒ»Ö¡£¡£¡£DBmRCA¼¼Êõ¾ßÓÐʱ¼äЧÂʸߡ¢Ñ¸ËÙ¶ÈÇ¿ºÍ²Ù×÷Á÷³Ì¼ò»¯µÈÓŵ㣬£¬£¬£¬£¬£¬ÎªÁÙ´²miRNAÆÊÎöÌṩÁËÒ»ÖÖ¿É¿¿µÄ¹¤¾ß£¬£¬£¬£¬£¬£¬ÓÐÍûÖúÁ¦·Î°©µÄÔçÆÚÕï¶ÏºÍÖÎÁÆ¡£¡£¡£

ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾

ͼ½âÕªÒª

ÁªÏµÍêÃÀÕæÈË

*
*
Ñ¡Ôñ¹ú¼Ò
*
ȪԴ£º
ÁªÏµÍêÃÀÕæÈË
*
*
*
ȪԴ£º
? service online

  • ÁôÑÔ
  • You can send email to contact us.
    ÓÊÏä
  • You can send email to contact us.
    µç»°
    ÍêÃÀÕæÈË¡¤WM(ÖйúÓÎ)¹Ù·½ÍøÕ¾ÁªÏµµç»°
    Öйú×ܲ¿
    18102225074(΢ÐÅͬºÅ)

  •  »Øµ½¶¥²¿